Cite

HARVARD Citation

    Liu, B. et al. (n.d.). Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record